Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (109)	6/13/2001 10:02:59 PM
From: scaram(o)uche	Respond to of 1005

>> not saying he has a position now << Nope. Leverage.... well, they can actually do what they claim fame for. Whether or not that will translate to utility for their customers is the question. Some leverage comes from their ongoing efforts to develop and/or in-license diagnostics. I used to think that their patient-specific "homozygous due to deletion of allele" concept for cancer was also "leverage". However, that's just science fiction for the mean time.